Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Sureda

Showing results (321-330 of 335) with videos related to

Pageof 34
Sort By:
Blood Advances|March 31, 2025
Autologous Stem Cell Transplantation for Relapsed/Refractory Large B Cell Lymphoma: Multicenter GETH-TC/GELTAMO StudyLeyre Bento, Antonio Gutiérrez, Carmen Martinez, et al.
Haematologica|May 9, 2024
Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donorsYoshiko Atsuta, Helen Baldomero, Daniel Neumann, et al.
Blood Cancer Journal|April 20, 2022
A simple score to predict early severe infections in patients with newly diagnosed multiple myelomaCristina Encinas, José-Ángel Hernandez-Rivas, Albert Oriol, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2022
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancerDavid J Pinato, Daniela Ferrante, Juan Aguilar-Company, et al.
The New England Journal of Medicine|January 5, 2022
Eltrombopag Added to Immunosuppression in Severe Aplastic AnemiaRégis Peffault de Latour, Austin Kulasekararaj, Simona Iacobelli, et al.
International Journal of Cancer|October 9, 2016
Identification of miRSNPs associated with the risk of multiple myelomaAngelica Macauda, Diego Calvetti, Giuseppe Maccari, et al.
Transplantation and Cellular Therapy|December 26, 2022
An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid LeukemiaMolly C Tokaz, Helen Baldomero, Andrew J Cowan, et al.
Blood|January 29, 2026
Immune biomarkers of increased infection risk in multiple myelomaAintzane Zabaleta, Luis-Esteban Tamariz-Amador, Ioannis V Kostopoulos, et al.
The Lancet. Oncology|June 6, 2022
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry studyDavid J Pinato, Juan Aguilar-Company, Daniela Ferrante, et al.
Cancer Discovery|August 2, 2020
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patientsDavid J Pinato, Alberto Zambelli, Juan Aguilar-Company, et al.
Pageof 34

Showing results (321-330 of 335) with videos related to

Sort By:
Pageof 34
Blood Advances|March 31, 2025
Autologous Stem Cell Transplantation for Relapsed/Refractory Large B Cell Lymphoma: Multicenter GETH-TC/GELTAMO StudyLeyre Bento, Antonio Gutiérrez, Carmen Martinez, et al.
Haematologica|May 9, 2024
Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donorsYoshiko Atsuta, Helen Baldomero, Daniel Neumann, et al.
Blood Cancer Journal|April 20, 2022
A simple score to predict early severe infections in patients with newly diagnosed multiple myelomaCristina Encinas, José-Ángel Hernandez-Rivas, Albert Oriol, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2022
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancerDavid J Pinato, Daniela Ferrante, Juan Aguilar-Company, et al.
The New England Journal of Medicine|January 5, 2022
Eltrombopag Added to Immunosuppression in Severe Aplastic AnemiaRégis Peffault de Latour, Austin Kulasekararaj, Simona Iacobelli, et al.
International Journal of Cancer|October 9, 2016
Identification of miRSNPs associated with the risk of multiple myelomaAngelica Macauda, Diego Calvetti, Giuseppe Maccari, et al.
Transplantation and Cellular Therapy|December 26, 2022
An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid LeukemiaMolly C Tokaz, Helen Baldomero, Andrew J Cowan, et al.
Blood|January 29, 2026
Immune biomarkers of increased infection risk in multiple myelomaAintzane Zabaleta, Luis-Esteban Tamariz-Amador, Ioannis V Kostopoulos, et al.
The Lancet. Oncology|June 6, 2022
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry studyDavid J Pinato, Juan Aguilar-Company, Daniela Ferrante, et al.
Cancer Discovery|August 2, 2020
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patientsDavid J Pinato, Alberto Zambelli, Juan Aguilar-Company, et al.
Pageof 34